M 15 Pill: white , round, 6mm
The pill with imprint M 15 (White, Round1) has been identified as Atropine Sulfate and Diphenoxylate Hydrochloride 0.025 mg / 2.5 mg and is used for Diarrhea. It belongs to the drug class antidiarrheals and is classified as a Schedule 5 controlled substance.
Images for M 15





Atropine Sulfate and Diphenoxylate Hydrochloride
- Imprint
- M 15
- Strength
- 0.025 mg / 2.5 mg
- Color
- White
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antidiarrheals
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 5 - Some potential for abuse
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
microcrystalline cellulose,
corn starch,
stearic acid
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00378-0415 (Discontinued) | Mylan Pharmaceuticals Inc. |
51079-0067 (Discontinued) | UDL Laboratories Inc. |
43063-0089 | PDRX Pharmaceuticals Inc. (repackager) |
49999-0207 | Lake Erie Medical and Surgical Supply (repackager) |
53002-0340 | Pharmedix (repackager) |
54569-0222 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
63874-0261 (Discontinued) | Altura Pharmaceuticals Inc. (repackager) |
67544-0021 | Prepak Systems Inc. (repackager) |
Related images for "M 15"
More about atropine / diphenoxylate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (68)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidiarrheals
- En español
Patient resources
- Atropine and diphenoxylate drug information
- Diphenoxylate and atropine (Advanced Reading)
- Diphenoxylate and Atropine Tablets
- Diphenoxylate and Atropine Solution
Other brands
Lomotil, Lomocot, Lonox, Vi-Atro
Professional resources
- Diphenoxylate monograph
- Diphenoxylate and Atropine (FDA)
- Diphenoxylate and Atropine Oral Solution (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.